These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 18515446

  • 1. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
    Ray R, Rukstalis M, Jepson C, Strasser A, Patterson F, Lynch K, Lerman C.
    J Psychopharmacol; 2009 Mar; 23(2):168-76. PubMed ID: 18515446
    [Abstract] [Full Text] [Related]

  • 2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S.
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G, Lemmonds CA, Kotler ML, Durcan MJ, Boyle J.
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [Abstract] [Full Text] [Related]

  • 4. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L, Busto UE, MacDonald A, Corrigall WA.
    Can J Clin Pharmacol; 2002 Dec; 9(4):175-82. PubMed ID: 12584575
    [Abstract] [Full Text] [Related]

  • 5. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
    Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR, Atomoxetine ADHD/SUD Study Group.
    Drug Alcohol Depend; 2008 Jul 01; 96(1-2):145-54. PubMed ID: 18403134
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
    Aubin HJ, Luthringer R, Demazières A, Dupont C, Lagrue G.
    Nicotine Tob Res; 2006 Apr 01; 8(2):193-201. PubMed ID: 16766412
    [Abstract] [Full Text] [Related]

  • 8. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
    Sofuoglu M, Babb D, Hatsukami DK.
    Nicotine Tob Res; 2003 Dec 01; 5(6):947-53. PubMed ID: 14668079
    [Abstract] [Full Text] [Related]

  • 9. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, Williams DW, Moore RJ, Levine L, Atomoxetine ADHD/ODD Study Group.
    Pediatrics; 2008 Feb 01; 121(2):e314-20. PubMed ID: 18245404
    [Abstract] [Full Text] [Related]

  • 10. Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes.
    Buchhalter AR, Acosta MC, Evans SE, Breland AB, Eissenberg T.
    Addiction; 2005 Apr 01; 100(4):550-9. PubMed ID: 15784070
    [Abstract] [Full Text] [Related]

  • 11. The effects of a prison smoking ban on smoking behavior and withdrawal symptoms.
    Cropsey KL, Kristeller JL.
    Addict Behav; 2005 Mar 01; 30(3):589-94. PubMed ID: 15718077
    [Abstract] [Full Text] [Related]

  • 12. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
    Adler LA, Sutton VK, Moore RJ, Dietrich AP, Reimherr FW, Sangal RB, Saylor KE, Secnik K, Kelsey DK, Allen AJ.
    J Clin Psychopharmacol; 2006 Dec 01; 26(6):648-52. PubMed ID: 17110824
    [Abstract] [Full Text] [Related]

  • 13. The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.
    Kleykamp BA, Jennings JM, Sams C, Weaver MF, Eissenberg T.
    Exp Clin Psychopharmacol; 2008 Apr 01; 16(2):99-112. PubMed ID: 18489014
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers.
    Harakas P, Foulds J.
    Psychopharmacology (Berl); 2002 May 01; 161(3):271-7. PubMed ID: 12021830
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.
    McRobbie H, Hajek P.
    Hum Psychopharmacol; 2004 Jan 01; 19(1):57-61. PubMed ID: 14716714
    [Abstract] [Full Text] [Related]

  • 17. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
    Rose JE, Herskovic JE, Behm FM, Westman EC.
    Nicotine Tob Res; 2009 Sep 01; 11(9):1067-75. PubMed ID: 19567826
    [Abstract] [Full Text] [Related]

  • 18. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
    Gadde KM, Yonish GM, Wagner HR, Foust MS, Allison DB.
    Int J Obes (Lond); 2006 Jul 01; 30(7):1138-42. PubMed ID: 16418753
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year.
    Buitelaar JK, Michelson D, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang S, Biederman J.
    Biol Psychiatry; 2007 Mar 01; 61(5):694-9. PubMed ID: 16893523
    [Abstract] [Full Text] [Related]

  • 20. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
    Thornley S, McRobbie H, Lin RB, Bullen C, Hajek P, Laugesen M, Senior H, Whittaker R.
    Nicotine Tob Res; 2009 Jun 01; 11(6):715-21. PubMed ID: 19454549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.